{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:24:32Z","timestamp":1780428272329,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":855,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32\u2010HL007150"],"award-info":[{"award-number":["T32\u2010HL007150"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32\u2010HL007439"],"award-info":[{"award-number":["T32\u2010HL007439"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL132557"],"award-info":[{"award-number":["R01HL132557"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1111\/jth.14804","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T15:08:59Z","timestamp":1584716939000},"page":"1586-1597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["FVIII activity following FVIII protein infusion or FVIII gene transfer predicts the bleeding risk in hemophilia A rats"],"prefix":"10.1016","volume":"18","author":[{"given":"Karin M.","family":"L\u00f6vgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte S.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Zintner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Kjelgaard\u2010Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"H\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maj","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wiinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paris","family":"Margaritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14804_bb0010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14804_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2516.2008.01837.x","article-title":"Clinical outcome of moderate haemophilia compared with severe and mild haemophilia","volume":"15","author":"den Uijl","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14804_bb0020","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/j.1538-7836.2010.03962.x","article-title":"Blood\u2010induced joint disease: the pathophysiology of hemophilic arthropathy","volume":"8","author":"Valentino","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0025","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0030","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0037-1615621","article-title":"Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis","volume":"85","author":"White","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1992.tb00546.x","article-title":"Twenty\u2010five years' experience of prophylactic treatment in severe haemophilia A and B","volume":"232","author":"Nilsson","year":"1992","journal-title":"J Intern Med"},{"key":"10.1111\/jth.14804_bb0040","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1651-2227.1980.tb07341.x","article-title":"Arthropathy in children with severe hemophilia A","volume":"69","author":"Soreff","year":"1980","journal-title":"Acta Paediatr Scand"},{"key":"10.1111\/jth.14804_bb0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2796.1994.tb00815.x","article-title":"A longitudinal study of orthopaedic outcomes for severe factor\u2010VIII\u2010deficient haemophiliacs. The Orthopaedic Outcome Study Group","volume":"236","author":"Aledort","year":"1994","journal-title":"J Intern Med"},{"key":"10.1111\/jth.14804_bb0050","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2516.2002.00695.x","article-title":"Prophylactic versus on\u2010demand treatment strategies for severe haemophilia: a comparison of costs and long\u2010term outcome","volume":"8","author":"Fischer","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14804_bb0055","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1111\/hae.13546","article-title":"Long\u2010term outcomes from prophylactic or episodic treatment of haemophilia A: a systematic review","volume":"24","author":"O'Hara","year":"2018","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14804_bb0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco\u2010Johnson","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14804_bb0065","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1538-7836.2011.04214.x","article-title":"A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)","volume":"9","author":"Gringeri","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0070","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-01-528414","article-title":"Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens","volume":"125","author":"Oldenburg","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.14804_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2516.2011.02682.x","article-title":"Identification and long\u2010term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis","volume":"18","author":"Olivieri","year":"2012","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14804_bb0080","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1365-2516.2002.00694.x","article-title":"Prophylactic treatment for severe haemophilia: comparison of an intermediate\u2010dose to a high\u2010dose regimen","volume":"8","author":"Fischer","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14804_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2516.2010.02383.x","article-title":"Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels","volume":"17","author":"den Uijl","year":"2011","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14804_bb0090","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2516.2011.02539.x","article-title":"Clinical severity of haemophilia A: does the classification of the 1950s still stand?","volume":"17","author":"den Uijl","year":"2011","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14804_bb0095","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1182\/blood-2009-05-220327","article-title":"Recombinant canine B\u2010domain\u2010deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model","volume":"114","author":"Sabatino","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.14804_bb0100","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/mt.2010.240","article-title":"Efficacy and safety of long\u2010term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectors","volume":"19","author":"Sabatino","year":"2011","journal-title":"Mol Ther"},{"key":"10.1111\/jth.14804_bb0105","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1073\/pnas.0409249102","article-title":"Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver\u2010directed neonatal gene therapy","volume":"102","author":"Xu","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14804_bb0110","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/jth.12635","article-title":"A novel F8\u2010\/\u2010 rat as a translational model of human haemophilia A","volume":"12","author":"Nielsen","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0115","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/jth.13328","article-title":"The F8(\u2010\/\u2010) rat as a model of hemophilic arthropathy","volume":"14","author":"S\u00f8rensen","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0120","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jth.13259","article-title":"Antibody response to recombinant human coagulation factor VIII in a new rat model of severe hemophilia A","volume":"14","author":"L\u00f6vgren","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","article-title":"Sex significantly influences transduction of murine liver by recombinant adeno\u2010associated viral vectors through an androgen\u2010dependent pathway","volume":"102","author":"Davidoff","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.14804_bb0130","doi-asserted-by":"crossref","first-page":"16063","DOI":"10.1038\/mtm.2016.63","article-title":"Potential for cellular stress response to hepatic factor VIII expression from AAV vector","volume":"3","author":"Zolotukhin","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1111\/jth.14804_bb0135","series-title":"Clinical Laboratory Parameters for the Crl:CD(SD) Rats","first-page":"9","author":"Giknis","year":"2006"},{"key":"10.1111\/jth.14804_bb0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/2040620712464509","article-title":"Factor VIII inhibitors in hemophilia A: rationale and latest evidence","volume":"4","author":"Witmer","year":"2013","journal-title":"Ther Adv Hematol"},{"key":"10.1111\/jth.14804_bb0145","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1055\/s-0033-1354422","article-title":"Arthropathy in patients with moderate hemophilia a: a systematic review of the literature","volume":"39","author":"Di Minno","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14804_bb0150","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1708483","article-title":"AAV5\u2010factor VIII gene transfer in severe hemophilia A","volume":"377","author":"Rangarajan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14804_bb0155","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1055\/s-0037-1613063","article-title":"Aberrant splicing and premature termination of transcription of the FVIII gene as a cause of severe canine hemophilia A: similarities with the intron 22 inversion mutation in human hemophilia","volume":"87","author":"Hough","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/j.seminhematol.2013.03.023","article-title":"Animal models of hemophilia and related bleeding disorders","volume":"50","author":"Lozier","year":"2013","journal-title":"Semin Hematol"},{"key":"10.1111\/jth.14804_bb0165","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1538-7836.2009.03697.x","article-title":"Clinical and molecular characterization of a re\u2010established line of sheep exhibiting hemophilia A","volume":"8","author":"Porada","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0170","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2018027219","article-title":"Gene\u2010based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats","volume":"3","author":"Zintner","year":"2019","journal-title":"Blood Adv"},{"key":"10.1111\/jth.14804_bb0175","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1160\/TH14-05-0407","article-title":"Benefits of prophylaxis versus on\u2010demand treatment in adolescents and adults with severe haemophilia A: the POTTER study","volume":"114","author":"Tagliaferri","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0180","doi-asserted-by":"crossref","first-page":"14036","DOI":"10.1038\/mtm.2014.36","article-title":"Bioengineered coagulation factor VIII enables long\u2010term correction of murine hemophilia A following liver\u2010directed adeno\u2010associated viral vector delivery","volume":"1","author":"Brown","year":"2014","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1111\/jth.14804_bb0185","doi-asserted-by":"crossref","first-page":"16064","DOI":"10.1038\/mtm.2016.64","article-title":"Overexpression of factor VIII after AAV delivery is transiently associated with cellular stress in hemophilia A mice","volume":"3","author":"Lange","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1111\/jth.14804_bb0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-0556-6-9","article-title":"Performance of AAV8 vectors expressing human factor IX from a hepatic\u2010selective promoter following intravenous injection into rats","volume":"6","author":"Graham","year":"2008","journal-title":"Genet Vaccines Ther"},{"key":"10.1111\/jth.14804_bb0195","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus\u2010associated virus vector\u2010mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14804_bb0200","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long\u2010term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14804_bb0205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV\u2010Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat Med"},{"key":"10.1111\/jth.14804_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053845","article-title":"Activation of the cellular unfolded protein response by recombinant adeno\u2010associated virus vectors","volume":"8","author":"Balakrishnan","year":"2013","journal-title":"PLoS One"},{"key":"10.1111\/jth.14804_bb0215","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fmicb.2014.00250","article-title":"Cellular unfolded protein response against viruses used in gene therapy","volume":"5","author":"Sen","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1111\/jth.14804_bb0220","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","article-title":"The mammalian unfolded protein response","volume":"74","author":"Schr\u00f6der","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"10.1111\/jth.14804_bb0225","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0037-1614450","article-title":"Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A","volume":"81","author":"Qian","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-0037-1612915","article-title":"Mechanism of the immune response to human factor VIII in murine hemophilia A","volume":"85","author":"Wu","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0235","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/s-0037-1613237","article-title":"Expression and characterization of recombinant murine factor VIII","volume":"88","author":"Doering","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0240","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2516.2010.02397.x","article-title":"Immunoglobulin isotypes and functional anti\u2010FVIII antibodies in response to FVIII treatment in Balb\/c and C57BL\/6 haemophilia A mice","volume":"17","author":"Qadura","year":"2011","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14804_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037671","article-title":"Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy","volume":"7","author":"Sack","year":"2012","journal-title":"PLoS One"},{"key":"10.1111\/jth.14804_bb0250","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/jth.13331","article-title":"Gene therapy for immune tolerance induction in hemophilia with inhibitors","volume":"14","author":"Arruda","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14804_bb0255","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1182\/blood-2010-06-288001","article-title":"Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy","volume":"116","author":"Finn","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1111\/jth.14804_bb0260","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.exphem.2011.09.001","article-title":"Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII\u2010expressing MSC","volume":"39","author":"Porada","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1111\/jth.14804_bb0265","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood-2012-10-462200","article-title":"Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant","volume":"121","author":"McIntosh","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14804_bb0270","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.omtm.2018.07.011","article-title":"An observational study from long\u2010term AAV re\u2010administration in two hemophilia dogs","volume":"10","author":"Sun","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"10.1111\/jth.14804_bb0275","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/hae.13899","article-title":"Rotational thromboelastometry can predict the probability of bleeding events in a translational rat model of haemophilia A following gene\u2010based FVIIa prophylaxis","volume":"26","author":"Larsen","year":"2019","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14804_bb0280","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2016.11.032","article-title":"Pathophysiology of hemophilic arthropathy and potential targets for therapy","volume":"115","author":"Pulles","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1111\/jth.14804_bb0285","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/jth.13811","article-title":"Effect of late prophylaxis in hemophilia on joint status: a randomized trial","volume":"15","author":"Manco\u2010Johnson","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"129","key":"10.1111\/jth.14804_bb0290","first-page":"2368","article-title":"Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project","volume":"2017","author":"Manco\u2010Johnson","year":"1999","journal-title":"Blood"},{"key":"10.1111\/jth.14804_bb0295","unstructured":"Thyme AP, V\u00f8ls KK, S\u00f8rensen KR, et al.Spontaneous bleeds in the elbows of F8\u2010\/\u2010 rats cause development of blood\u2010induced joint disease closely resembling human hemophilic arthropathy. World Federation of Hemophilia World Congress. 26 July 2016. Orlando, FL (USA)."}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14804","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14804","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14804","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622013228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622013228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:29:30Z","timestamp":1761535770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622013228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1538783622013228"],"URL":"https:\/\/doi.org\/10.1111\/jth.14804","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FVIII activity following FVIII protein infusion or FVIII gene transfer predicts the bleeding risk in hemophilia A rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}